EMA — authorised 25 July 2019
- Marketing authorisation holder: Advanced Accelerator Applications
- Status: approved
EMA authorised R-Gene 10 on 25 July 2019
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 25 July 2019.
Advanced Accelerator Applications holds the EU marketing authorisation.